These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35972550)

  • 1. CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging.
    O'Malley RB; Cox D; Soloff EV; Zečević M; Green S; Coveler A; Busey JM; Wang CL
    Abdom Radiol (NY); 2022 Nov; 47(11):3770-3781. PubMed ID: 35972550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience.
    Hamdy A; Ichikawa Y; Toyomasu Y; Nagata M; Nagasawa N; Nomoto Y; Sami H; Sakuma H
    Radiology; 2019 Sep; 292(3):628-635. PubMed ID: 31287389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of wide detector CT perfusion imaging performed during routine staging and restaging of pancreatic ductal adenocarcinoma.
    O'Malley RB; Soloff EV; Coveler AL; Cox DH; Desai N; Busey JM; Valentin GM; Wang CL
    Abdom Radiol (NY); 2021 May; 46(5):1992-2002. PubMed ID: 33079256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
    Aslan S; Nural MS; Camlidag I; Danaci M
    Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
    Panda A; Garg I; Truty MJ; Kline TL; Johnson MP; Ehman EC; Suman G; Anaam DA; Kemp BJ; Johnson GB; Halfdanarson TR; Venkatesh SK; Fidler JL; Goenka AH
    AJR Am J Roentgenol; 2021 Sep; 217(3):730-740. PubMed ID: 33084382
    [No Abstract]   [Full Text] [Related]  

  • 6. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.
    Amer AM; Zaid M; Chaudhury B; Elganainy D; Lee Y; Wilke CT; Cloyd J; Wang H; Maitra A; Wolff RA; Varadhachary G; Overman MJ; Lee JE; Fleming JB; Tzeng CW; Katz MH; Holliday EB; Krishnan S; Minsky BD; Herman JM; Taniguchi CM; Das P; Crane CH; Le O; Bhosale P; Tamm EP; Koay EJ
    Cancer; 2018 Apr; 124(8):1701-1709. PubMed ID: 29370450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computed Tomography Perfusion Analysis of Pancreatic Adenocarcinoma using Deconvolution, Maximum Slope, and Patlak Methods - Evaluation of Diagnostic Accuracy and Interchangeability of Cut-Off Values.
    Koell M; Klauss M; Skornitzke S; Mayer P; Fritz F; Stiller W; Grenacher L
    Rofo; 2021 Sep; 193(9):1062-1073. PubMed ID: 33772484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
    Borhani AA; Dewan R; Furlan A; Seiser N; Zureikat AH; Singhi AD; Boone B; Bahary N; Hogg ME; Lotze M; Zeh HJ; Tublin ME
    AJR Am J Roentgenol; 2020 Feb; 214(2):362-369. PubMed ID: 31799875
    [No Abstract]   [Full Text] [Related]  

  • 9. Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth.
    Mayer P; Fritz F; Koell M; Skornitzke S; Bergmann F; Gaida MM; Hackert T; Maier-Hein K; Laun FB; Kauczor HU; Grenacher L; Klauß M; Stiller W
    Cancer Imaging; 2021 Jan; 21(1):13. PubMed ID: 33468259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging.
    Delrue L; Blanckaert P; Mertens D; Cesmeli E; Ceelen WP; Duyck P
    J Comput Assist Tomogr; 2011; 35(4):434-8. PubMed ID: 21765297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience.
    Bellomi M; Petralia G; Sonzogni A; Zampino MG; Rocca A
    Radiology; 2007 Aug; 244(2):486-93. PubMed ID: 17641369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative CT perfusion imaging in patients with pancreatic cancer: a systematic review.
    Perik TH; van Genugten EAJ; Aarntzen EHJG; Smit EJ; Huisman HJ; Hermans JJ
    Abdom Radiol (NY); 2022 Sep; 47(9):3101-3117. PubMed ID: 34223961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy.
    Rana L; Sharma S; Sood S; Singh B; Gupta MK; Minhas RS; Jhobta A; Bhatia V; Venkat B
    Eur J Radiol Open; 2015; 2():46-54. PubMed ID: 26937435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CT perfusion imaging in patients with variously differentiated gastric adenocarcinoma.
    Sun ZQ; Cheng XF; Ge YX; Chen L; Yue JG; Jin LF; Xie ZH; Zhang HD; Xuan YH
    J Xray Sci Technol; 2015; 23(6):737-44. PubMed ID: 26756409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unresectable pancreatic ductal adenocarcinoma: Role of CT quantitative imaging biomarkers for predicting outcomes of patients treated with chemotherapy.
    Cheng SH; Cheng YJ; Jin ZY; Xue HD
    Eur J Radiol; 2019 Apr; 113():188-197. PubMed ID: 30927946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of CT Radiomics Features in Differentiation of Pancreatic Ductal Adenocarcinoma From Normal Pancreatic Tissue.
    Chu LC; Park S; Kawamoto S; Fouladi DF; Shayesteh S; Zinreich ES; Graves JS; Horton KM; Hruban RH; Yuille AL; Kinzler KW; Vogelstein B; Fishman EK
    AJR Am J Roentgenol; 2019 Aug; 213(2):349-357. PubMed ID: 31012758
    [No Abstract]   [Full Text] [Related]  

  • 17. Whole-tumour CT-perfusion of unresectable lung cancer for the monitoring of anti-angiogenetic chemotherapy effects.
    Fraioli F; Anzidei M; Serra G; Liberali S; Fiorelli A; Zaccagna F; Longo F; Anile M; Catalano C
    Br J Radiol; 2013 Sep; 86(1029):20120174. PubMed ID: 23908346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging.
    Xu J; Liang Z; Hao S; Zhu L; Ashish M; Jin C; Fu D; Ni Q
    Abdom Imaging; 2009 Nov; 34(6):759-66. PubMed ID: 19672566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfusion CT - Can it resolve the pancreatic carcinoma versus mass forming chronic pancreatitis conundrum?
    Yadav AK; Sharma R; Kandasamy D; Pradhan RK; Garg PK; Bhalla AS; Gamanagatti S; Srivastava DN; Sahni P; Upadhyay AD
    Pancreatology; 2016; 16(6):979-987. PubMed ID: 27568845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfusion CT - A novel quantitative and qualitative imaging biomarker in gastric cancer.
    Kruk-Bachonko J; Krupski W; Czechowski M; Kurys-Denis E; Mądro P; Sierocińska-Sawa J; Dąbrowski A; Wallner G; Skoczylas T
    Eur J Radiol; 2017 Oct; 95():399-408. PubMed ID: 28987697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.